Posted by Michael Wonder on 31 Mar 2022
EMA starts review of Sanofi-GSK COVID vaccine application
30 March 2022 - The European Union's drug regulator has started reviewing Sanofi and its British partner GlaxoSmithKline's application seeking conditional authorisation for their COVID-19 vaccine, the agency said on Wednesday.
The drug makers had earlier said that they would seek regulatory approval for their COVID-19 vaccine to be used as a booster as well as a standalone two dose shot.
